A higher systemic inflammatory burden was independently associated with recorded all-cause mortality across the spectrum of heart failure spectrum, and its incremental value appears modest.
Abstract
Background: Inflammation is increasingly recognized as an important contributor to the progression of heart failure and may partly explain differences in prognosis beyond conventional clinical characteristics. Simple laboratory-based inflammatory indices may offer additional prognostic information, but their value across different heart failure phenotypes remains uncertain. Objectives: To investigate the association between the systemic immune-inflammation index and recorded all-cause mortality across the spectrum of heart failure and to evaluate its incremental prognostic value beyond conventional clinical and laboratory variables. Patients and Methods: We evaluated the association between the systemic immune-inflammation index (SII) and recorded all-cause mortality in patients with heart failure. Multivariable logistic regression models included age, sex, heart failure phenotype, cardiovascular comorbidities, NT-proBNP, renal function, and hemoglobin. Model discrimination and calibration were assessed, and additional analyses evaluated multicollinearity, interaction with heart failure phenotype, and the functional form of the association. Results: Among 637 patients, mortality status was available for 634, of whom 165 died (26.0%). After multivariable adjustment, each doubling of SII was associated with higher odds of recorded all-cause mortality (OR 1.42, 95% CI 1.19–1.70; p < 0.001). Previous myocardial infarction, atrial fibrillation, and NT-proBNP also remained independently associated with mortality, whereas LVEF phenotype was not. No significant interaction was observed between SII and heart failure phenotype. Adding SII improved overall model fit (likelihood-ratio χ2 = 16.17; p < 0.001) and increased the AUC from 0.710 to 0.732, although the difference in discrimination was not statistically significant (DeLong p = 0.076). There was no convincing evidence of marked non-linearity. Conclusions: A higher systemic inflammatory burden was independently associated with recorded all-cause mortality across the heart failure spectrum. This readily available marker may provide complementary prognostic information, but its incremental value appears modest. External validation is needed before it can be considered for routine risk assessment.
Background/objectives Heart failure (HF) is one of the leading causes of death and impairs quality of life worldwide. Systemic inflammation has been increasingly recognized as a major contributor to adverse outcomes in patients with heart failure. The Inflammatory Burden Index (IBI), a composite marker integrating C-re...
Rüstem Yilmaz, K. Toprak, A. Karagoz et al.· Frontiers in Cardiovascular...· 0 citations
Background/Objectives: Acute coronary syndrome (ACS) and acute decompensated heart failure (ADHF) are associated with substantial short-term morbidity and mortality. The systemic immune–inflammation index (SII) reflects inflammatory and thrombotic activity, but its prognostic value beyond conventional biomarkers and cl...
Y. Khan, Sudesh Prajapathi, Mahadev Meena et al.· Journal of Clinical Medicine· 0 citations
Background: Frailty is highly prevalent in acute heart failure (AHF), yet whether it is more strongly associated with all-cause mortality or with non-fatal heart-failure events, and whether it adds information beyond cardiac severity, is seldom examined. Methods: In a prospective single-center registry of 530 consecuti...
G. Aletras, M. Marketou, M. Bachlitzanaki et al.· Medicina· 0 citations
Background Heart failure (HF) is a global health problem with high mortality rates. Systemic inflammation and neurohumoral dysfunction play an important role in its pathophysiology. Unlike other subtypes, HF with preserved ejection fraction (HFpEF) represents a highly heterogeneous group of patients. Therefore, the phe...
Mustafa Özkoç, Selim Aydemir, M. Özmen et al.· International Journal of Gen...· 0 citations
Hematological indices derived from complete blood count, including neutrophil-to-lymphocyte ratio (NLR), red cell distribution width (RDW), and platelet-to-lymphocyte ratio (PLR), showed limited individual discrimination and should not be considered standalone prognostic tools.
Cristian Maghet, D. Arnăutu, S. Arnăutu et al.· Biomedicines· 0 citations
Higher SIRI, SII, NLR, and MLR levels were associated with an increased risk of adverse cardiovascular outcomes in patients with HFrEF, and SIRI showed numerically better discrimination among hospitalized patients with HFrEF in this cohort.
Zhao-Rui Qiu, Peng-Hui Cui, Xin-Tian Cai et al.· International Journal of Gen...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.